Search

Author/Creator Hirasawa, Makoto

1. Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. Issue 10 (8th August 2017)

Authors:
Honma, Daisuke; Kanno, Osamu; Watanabe, Jun; Kinoshita, Junzo; Hirasawa, Makoto; Nosaka, Emi; Shiroishi, Machiko; Takizawa, Takeshi; Yasumatsu, Isao; Horiuchi, Takao; Nakao, Akira; Suzuki, Keisuke; Yamasaki, Tomonori; Nakajima, Katsuyoshi; Hayakawa, Miho; Yamazaki, Takanori; Yadav, Ajay Singh; Ad...
Journal:
Cancer science
Issue:
Volume 108:Issue 10(2017)
Page Start:
2069
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer. Issue 1 (16th January 2020)

Authors:
Yenerall, Paul; Das, Amit K.; Wang, Shan; Kollipara, Rahul K.; Li, Long Shan; Villalobos, Pamela; Flaming, Josiah; Lin, Yu-Fen; Huffman, Kenneth; Timmons, Brenda C.; Gilbreath, Collin; Sonavane, Rajni; Kinch, Lisa N.; Rodriguez-Canales, Jaime; Moran, Cesar; Behrens, Carmen; Hirasawa, Makoto; Taka...
Journal:
Cell chemical biology
Issue:
Volume 27:Issue 1(2020)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search